Abstract：
BACKGROUND: Although rare, as the population ages, abdominal aortic aneurysm synchronous to abdominal malignancies, as renal cell carcinoma, is expected to become more prevalent. There are only two case reports of minimally invasive surgeries to treat these synchronous diseases, with endovascular aortic repair and laparoscopic nephrectomy, but they were performed in two stages, with iodinated contrast and without robotic assistance.
METHODS: We herein present a case of a 71-year-old patient with chronic kidney disease, a 6.4 cm infra-renal abdominal aortic aneurysm associated and a suspicious 6 cm solid-cystic expansile lesion in the right kidney, successfully treated at one stage with endovascular aortic repair using carbon dioxide as a contrast medium and with robotic right partial nephrectomy, aiming to preserve the renal function as much as possible. The patient\'s postoperative course was free of complications with hospital discharge on the fifth postoperative day, with a serum creatinine of 0.84 mg/dL.
CONCLUSIONS: single-stage minimally invasive surgical treatment of AAA and RCC can be a safe and feasible approach. Combining a robot-assisted laparoscopic partial nephrectomy with an EVAR using carbon dioxide as a contrast medium was safe and successfully preserved renal function.
METHODS: We herein present a case of a 71-year-old patient with chronic kidney disease, a 6.4 cm infra-renal abdominal aortic aneurysm associated and a suspicious 6 cm solid-cystic expansile lesion in the right kidney, successfully treated at one stage with endovascular aortic repair using carbon dioxide as a contrast medium and with robotic right partial nephrectomy, aiming to preserve the renal function as much as possible. The patient\'s postoperative course was free of complications with hospital discharge on the fifth postoperative day, with a serum creatinine of 0.84 mg/dL.
CONCLUSIONS: single-stage minimally invasive surgical treatment of AAA and RCC can be a safe and feasible approach. Combining a robot-assisted laparoscopic partial nephrectomy with an EVAR using carbon dioxide as a contrast medium was safe and successfully preserved renal function.
摘要：
背景：虽然罕见，随着人口老龄化,腹主动脉瘤与腹部恶性肿瘤同步，作为肾细胞癌，预计将变得更加普遍。目前只有2例微创手术治疗这些同步疾病的病例报告,血管内主动脉修复术和腹腔镜肾切除术，但是他们分两个阶段进行，碘化对比，没有机器人的帮助。
方法：我们在此介绍一例71岁的慢性肾病患者，一个6.4厘米的肾下腹主动脉瘤相关和一个可疑的6厘米实囊性扩张性病变在右肾，使用二氧化碳作为造影剂的血管内主动脉修复术和机器人右部分肾切除术在一个阶段成功治疗，目的是尽可能保护肾功能。患者术后病程无并发症，术后第五天出院，血清肌酐为0.84mg/dL。
结论：单阶段微创手术治疗AAA和RCC是一种安全可行的方法。将机器人辅助的腹腔镜部分肾切除术与使用二氧化碳作为造影剂的EVAR相结合是安全的，并成功地保留了肾功能。
方法：我们在此介绍一例71岁的慢性肾病患者，一个6.4厘米的肾下腹主动脉瘤相关和一个可疑的6厘米实囊性扩张性病变在右肾，使用二氧化碳作为造影剂的血管内主动脉修复术和机器人右部分肾切除术在一个阶段成功治疗，目的是尽可能保护肾功能。患者术后病程无并发症，术后第五天出院，血清肌酐为0.84mg/dL。
结论：单阶段微创手术治疗AAA和RCC是一种安全可行的方法。将机器人辅助的腹腔镜部分肾切除术与使用二氧化碳作为造影剂的EVAR相结合是安全的，并成功地保留了肾功能。
